CPT1A and Stroke: Stroke subtype-specific interventions address distinct metabolic vulnerabilities: cardioembolic strokes with high TMAO benefit from fecal transplant and CPT1A inhibitors, while lacunar strokes with NAD+ depletion respond to NAD+ precursors and time-restricted feeding (TRF) (Fig. 5a & Table S5).